News

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ ...
Findings showed mNexspike showed a 9.3% (99.4% CI, -6.6, 22.8) higher relative vaccine efficacy compared with Moderna’s original COVID-19 vaccine.
"The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19," said Stéphane Bancel, CEO of Moderna. "COVID-19 ...